Advertisement
Cronos Group Inc.

Cronos Group Inc. (CRON) Stock Overview

Explore Cronos Group Inc.’s financial performance, market position, analyst ratings, and future outlook.

CRONNASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$2.68
$0.07(2.55%)
U.S. Market opens in 51h 8m
Advertisement

Cronos Group Inc. (CRON)

Meyka AI Score

Z

Key Financials

Market Cap1B
P/E Ratio-519.18
EPS (TTM)$-0.02
ROE-0.00%
Fundamental Analysis

AI Price Forecasts

1 Month$2.27
3 Months$3.22
1 Year Target$3.04

CRON Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cronos Group Inc. (CRON) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 52.68, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $3.04.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -519.18 and a market capitalization of 1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.55%
5-Day Change
-4.96%
1-Month Change
-3.25%
3-Month Change
7.63%
6-Month Change
-18.04%
Year-to-Date (YTD) Change
1.90%
1-Year Change
34.67%
3-Year Change
53.14%
5-Year Change
-69.79%
All-Time (Max) Change
1524.24%

Contact Information

14165040004
111 Peter Street, Stayner, ON, M5V 2H1

Company Facts

459 Employees
IPO DateFeb 27, 2018
CountryCA
Actively Trading

Frequently Asked Questions